April, 2019

pills

Opioid Maker Settles $270 Million Oklahoma Lawsuit

Purdue, manufacturer of the controversial opioid OxyContin, settled a lawsuit brought by the Oklahoma Attorney General for $270 million. A detailed article on the nature of the landmark settlement is available here. A suit filed by Oklahoma Attorney General Mike Hunter against Purdue Pharma alleged the drug manufacturer—through aggressive marketing of OxyContin—fueled the opioid crisis […]

April 23rd, 2019 Read More
Chad McLain on Good Day Tulsa

Chad McLain Discusses the Dangers of Distracted Driving on Good Day Tulsa

Attorney Chad McLain of Graves McLain visited Good Day Tulsa on KTUL on April 18th to discuss April as Distracted Driving Awareness Month. During the discussion, he addressed the risks of distracted driving as well as the penalties distracted drivers can face. Watch the video here: What is Distracted Driving? According to the National Highway […]

April 19th, 2019 Read More
pills and stethoscope

FDA Recalls Irbesartan Over Potential Cancer Risk

Another manufacturer has issued recalls for Irbesartan after the frequently prescribed blood-pressure medication tested positive for a probable human carcinogen. A detailed article examining the latest in a series of recalls is available here. According to the United States Food and Drug Administration (FDA), a pharmaceutical manufacturer has recalled multiple lots of Irbesartan. These drugs, […]

April 15th, 2019 Read More
school bus

Stillwater Teen Struck by Vehicle After Exiting School Bus

Police in Stillwater, Oklahoma, a town 70 miles west of Tulsa, report that a local student has been hospitalized after he was struck by a car as he exited a school bus. An article on this emerging story is available here. The accident occurred near Husband Street and Miller Avenue. Police sources indicate the 15-year-old […]

April 8th, 2019 Read More
Person having their blood pressure taken

Losartan Recalled Due to Contamination

Drug manufacturer Camber Pharmaceuticals has issued a recall for large quantities of Losartan. An article on this emerging story is available here. Currently, no patients have reported any adverse effects related to potential contamination. Patients are advised to speak with a qualified physician before discontinuing the drug. The National Drug Code (NDC) numbers associated with […]

April 1st, 2019 Read More